126 related articles for article (PubMed ID: 9013415)
1. An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1996; 103(11):1287-94. PubMed ID: 9013415
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated electroconvulsive shock on striatal L-dopa and dopamine metabolism: an in vivo study.
Brannan T; Martínez-Tica J; Yahr MD
J Neural Transm Park Dis Dement Sect; 1993; 6(1):35-44. PubMed ID: 7692872
[TBL] [Abstract][Full Text] [Related]
3. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
[TBL] [Abstract][Full Text] [Related]
4. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
Napolitano A; Zürcher G; Da Prada M
Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
[TBL] [Abstract][Full Text] [Related]
5. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
Gołembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
Törnwall M; Kaakkola S; Tuomainen P; Kask A; Männistö PT
Br J Pharmacol; 1994 May; 112(1):13-8. PubMed ID: 7518301
[TBL] [Abstract][Full Text] [Related]
7. Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
Dethy S; Laute MA; Damhaut P; Goldman S
J Neural Transm (Vienna); 1999; 106(2):145-58. PubMed ID: 10226935
[TBL] [Abstract][Full Text] [Related]
8. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
Brannan T; Bhardwaj A; Martinez-Tica J; Weinberger J; Yahr M
J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388
[TBL] [Abstract][Full Text] [Related]
9. Effects of zonisamide on dopaminergic system.
Okada M; Kaneko S; Hirano T; Mizuno K; Kondo T; Otani K; Fukushima Y
Epilepsy Res; 1995 Nov; 22(3):193-205. PubMed ID: 8991786
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Huang L; Deng M; Zhang S; Fang Y; Li L
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
[TBL] [Abstract][Full Text] [Related]
11. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
Lacombe E; Carcenac C; Boulet S; Feuerstein C; Bertrand A; Poupard A; Savasta M
Eur J Neurosci; 2007 Sep; 26(6):1670-80. PubMed ID: 17822436
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic studies of L-dopa in rats. II. Effect of L-dopa on dopamine and dopamine metabolite concentration in rat striatum.
Sato S; Koitabashi T; Koshiro A
Biol Pharm Bull; 1994 Dec; 17(12):1622-9. PubMed ID: 7735207
[TBL] [Abstract][Full Text] [Related]
13. Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats.
Borah A; Mohanakumar KP
Cell Mol Neurobiol; 2007 Dec; 27(8):985-96. PubMed ID: 17934805
[TBL] [Abstract][Full Text] [Related]
14. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation.
Brannan T; Prikhojan A; Yahr MD
Brain Res; 1998 Feb; 784(1-2):148-53. PubMed ID: 9518585
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: a microdialysis study.
Sarre S; Smolders I; Thorré K; Ebinger G; Michotte Y
J Neural Transm (Vienna); 1997; 104(11-12):1215-28. PubMed ID: 9503267
[TBL] [Abstract][Full Text] [Related]
17. In vivo microdialysis to determine the relative pharmacokinetics of drugs.
Nakashima M; Zhao MF; Nakashima MN; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
Biol Pharm Bull; 1996 Jul; 19(7):988-94. PubMed ID: 8839975
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.
Jordan S; Koprivica V; Dunn R; Tottori K; Kikuchi T; Altar CA
Eur J Pharmacol; 2004 Jan; 483(1):45-53. PubMed ID: 14709325
[TBL] [Abstract][Full Text] [Related]
19. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat.
Brannan T; Prikhojan A; Yahr MD
Brain Res; 1996 Apr; 718(1-2):165-8. PubMed ID: 8773780
[TBL] [Abstract][Full Text] [Related]
20. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]